Correlation Between Praxis Precision and Catalyst Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Praxis Precision and Catalyst Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Praxis Precision and Catalyst Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Praxis Precision Medicines and Catalyst Biosciences, you can compare the effects of market volatilities on Praxis Precision and Catalyst Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Praxis Precision with a short position of Catalyst Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Praxis Precision and Catalyst Biosciences.

Diversification Opportunities for Praxis Precision and Catalyst Biosciences

0.54
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Praxis and Catalyst is 0.54. Overlapping area represents the amount of risk that can be diversified away by holding Praxis Precision Medicines and Catalyst Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Catalyst Biosciences and Praxis Precision is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Praxis Precision Medicines are associated (or correlated) with Catalyst Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Catalyst Biosciences has no effect on the direction of Praxis Precision i.e., Praxis Precision and Catalyst Biosciences go up and down completely randomly.

Pair Corralation between Praxis Precision and Catalyst Biosciences

If you would invest  5,829  in Praxis Precision Medicines on September 15, 2024 and sell it today you would earn a total of  1,271  from holding Praxis Precision Medicines or generate 21.8% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy1.56%
ValuesDaily Returns

Praxis Precision Medicines  vs.  Catalyst Biosciences

 Performance 
       Timeline  
Praxis Precision Med 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Praxis Precision Medicines are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent basic indicators, Praxis Precision showed solid returns over the last few months and may actually be approaching a breakup point.
Catalyst Biosciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Catalyst Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy forward indicators, Catalyst Biosciences is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Praxis Precision and Catalyst Biosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Praxis Precision and Catalyst Biosciences

The main advantage of trading using opposite Praxis Precision and Catalyst Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Praxis Precision position performs unexpectedly, Catalyst Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Catalyst Biosciences will offset losses from the drop in Catalyst Biosciences' long position.
The idea behind Praxis Precision Medicines and Catalyst Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.

Other Complementary Tools

Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Fundamental Analysis
View fundamental data based on most recent published financial statements